| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/01/1999 | WO1999032436A1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas |
| 07/01/1999 | WO1999032148A1 Methods and compositions for inhibiting tumor cell growth |
| 07/01/1999 | WO1999032141A1 Ifnar2/ifn complex |
| 07/01/1999 | WO1999032118A1 Molecular dispersion composition with enhanced bioavailability |
| 07/01/1999 | WO1999032114A1 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases |
| 07/01/1999 | WO1999032111A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS |
| 07/01/1999 | WO1999032106A1 Inhibition of raf kinase using substituted heterocyclic ureas |
| 07/01/1999 | WO1999032098A2 Combination of a ramba and a tocopherol |
| 07/01/1999 | WO1999025832A8 Toso |
| 07/01/1999 | WO1999020747A3 HUMAN CHECKPOINT KINASE, hCDS1, COMPOSITIONS AND METHODS |
| 07/01/1999 | WO1999020121A3 Methods for obtaining protein mixtures and control factors from wound granulation, epithelialization or determined blastocyst tissue |
| 07/01/1999 | WO1999015167A3 Use of citrus limonoids and flavonoids as well as tocotrienols for the treatment of cancer |
| 07/01/1999 | WO1999012962A8 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases |
| 07/01/1999 | WO1999010014A3 Receptor-mediated gene delivery using bacteriophage vectors |
| 07/01/1999 | DE19758400A1 Tumorvakzine für MUC1-positive Karzinome Tumor vaccine for MUC1-positive carcinomas |
| 07/01/1999 | DE19757250A1 Insulin-like growth factor binding protein und seine Verwendung Insulin-like growth factor binding protein and its use |
| 07/01/1999 | DE19756261A1 Neue arylsubstituierte Pyridylalkan-, alken- und alkincarbonsäureamide New pyridylalkane aryl, alkene and alkincarbonsäureamide |
| 07/01/1999 | DE19756236A1 Neue piperazinylsubstituierte Pyridylalkan-, alken- und -alkincarbonsäureamide New piperazinyl substituted pyridylalkane, alkene and -alkincarbonsäureamide |
| 07/01/1999 | DE19756235A1 Neue piperidinylsubstituierte Pyridylalkan- alken- und -alkincarbonsäureamide New piperidinylsubstituierte pyridylalkane alkene and -alkincarbonsäureamide |
| 07/01/1999 | DE19756212A1 Neue, mit einem cyclischen Imid substituierte Pyridylalkan-, alken- und -alkincarbonsäureamide Novel substituted with a cyclic imide pyridylalkane, alkene and -alkincarbonsäureamide |
| 07/01/1999 | CA2315974A1 Insulin-like growth factor binding protein fragments and the utilization thereof |
| 07/01/1999 | CA2315788A1 Human nucleotide pyrophosphohydrolase-2 |
| 07/01/1999 | CA2315720A1 Inhibition of p38 kinase activity using substituted heterocyclic ureas |
| 07/01/1999 | CA2315245A1 Secreted proteins and polynucleotides encoding them |
| 07/01/1999 | CA2315037A1 Methods and compositions for inhibiting tumor cell growth |
| 07/01/1999 | CA2312826A1 Hemiasterlin analogs |
| 07/01/1999 | CA2311416A1 Prostate cancer gene |
| 07/01/1999 | CA2303483A1 Sag: sensitive to apoptosis gene |
| 06/30/1999 | EP0926237A2 Nucleic acid constructs for gene therapy, whose activity is influenced by inhibitors of cyclin-dependent kinases |
| 06/30/1999 | EP0926236A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for inhibitor screening, diagnosis or therapy |
| 06/30/1999 | EP0925359A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 06/30/1999 | EP0925307A1 Enzyme and dna sequence encoding same |
| 06/30/1999 | EP0925301A1 Highly lipophilic camptothecin derivatives |
| 06/30/1999 | EP0925298A1 Substituted 6,6-hetero-bicyclic derivatives |
| 06/30/1999 | EP0925289A1 Matrix metalloproteinase inhibitors |
| 06/30/1999 | EP0925287A1 Heterocyclic metalloprotease inhibitors |
| 06/30/1999 | EP0925278A1 Cytostatic hydroxamic acid derivatives |
| 06/30/1999 | EP0925069A1 Means for treating prostate hypertrophy and prostate cancer |
| 06/30/1999 | EP0924986A1 Antioxidant derived from lentil and its preparation and uses |
| 06/30/1999 | EP0924985A1 Method for inhibiting the expression of fas |
| 06/30/1999 | CN1221452A Hybrid interferon compositions and method of use |
| 06/30/1999 | CN1221449A Modulators of TNF receptor associated factor (TRAF), their preparation and use |
| 06/30/1999 | CN1221421A Novel water-soluble c-ring analogues of 20(S)-camptothecin |
| 06/30/1999 | CN1221420A Novel water-soluble analogues of 20(S)-camptothecin |
| 06/30/1999 | CN1221409A Bibenzo-oxazepine and dioxepine derivatives and their use as anti-tumor agents |
| 06/30/1999 | CN1221349A Cellular vaccines immunotherapeutics and methods for their preparation |
| 06/30/1999 | CN1221344A Extractable compounds and method for making and using the same |
| 06/30/1999 | CN1221343A Phosphatidic acid-comprising compositions |
| 06/30/1999 | CN1220997A Recombination human tumour necrofactor and preparation method |
| 06/30/1999 | CN1220879A Medical preparation for tumour |
| 06/30/1999 | CN1043884C New substituted azacylobutanone, preparation method and medicinal use thereof |
| 06/30/1999 | CN1043883C Vitamin D analogues, medicinal composition containing the same and medical use thereof |
| 06/29/1999 | US5917062 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs |
| 06/29/1999 | US5917056 10-deacetyl-14β-hydroxybaccactine III derivatives, a process for the preparation thereof and formulations containing them |
| 06/29/1999 | US5916897 Process for the preparation of 9-amino camptothecin |
| 06/29/1999 | US5916896 Antitumor agents; leukemia therapy |
| 06/29/1999 | US5916894 Substituted 06-benzylguanines and 6(4)-benzyloxypyrimidines |
| 06/29/1999 | US5916887 4-substituted-3-(2-amino-2-cycloalkyl methyl)-acetamido azetidin-2-one derivatives as cysteine proteinase regulators |
| 06/29/1999 | US5916803 Target cell-specific non-viral vectors for inserting genes into cells, pharmaceutical compositions comprising such vectors and their use |
| 06/29/1999 | US5916793 Arginine deiminase derived from Mycoplasma arthritidis and polymer conjugates containing the same |
| 06/29/1999 | US5916792 Jak3 plays a role in the growth factor modulated differentiation/proliferation of the stem/progenitor cells. |
| 06/29/1999 | US5916755 Relates to genes which encode novel proteins related to a family of receptor proteins typified by two related membrane spanning tyrosine kinases: the epidermal growth factor receptor, which is encoded by the erbb gene, and the receptor |
| 06/29/1999 | US5916596 Water insoluble drugs and drug delivery |
| 06/29/1999 | US5916582 Aqueous formulations of peptides |
| 06/29/1999 | US5916561 Monoclonal antibody against CD44v6 |
| 06/29/1999 | US5916559 For organ transplants |
| 06/29/1999 | US5916539 Superparamagnetic particles, process for producing the same and their use |
| 06/29/1999 | CA2132936C Stabilized pharmaceutical compositions and stabilizing solvent |
| 06/29/1999 | CA2016584C Anthracycline conjugates having a novel linker and methods for their production |
| 06/29/1999 | CA1340615C Compouds effective in inducing cell differentiation and process for preparing same |
| 06/29/1999 | CA1340614C Cyclopentano-vitamin d analogs |
| 06/29/1999 | CA1340612C Cell specific cytotoxic agents derived from diphtheria toxin |
| 06/24/1999 | WO1999031262A2 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | WO1999031261A1 SELECTIVE KILLING AND DIAGNOSIS OF p53+ NEOPLASTIC CELLS |
| 06/24/1999 | WO1999031252A1 Ubiquitin-like conjugating protein |
| 06/24/1999 | WO1999031232A1 Human brain derived kcnq2 potassium channel |
| 06/24/1999 | WO1999031225A2 Human phosphatases |
| 06/24/1999 | WO1999031140A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/24/1999 | WO1999031135A1 Proteins for cancer cell specific induction of apoptosis and method for isolation thereof |
| 06/24/1999 | WO1999031128A2 Human tumor necrosis factor-r2-like proteins |
| 06/24/1999 | WO1999031119A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes |
| 06/24/1999 | WO1999031116A1 Human dendriac and brainiac-3 |
| 06/24/1999 | WO1999031099A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031088A1 Triazine angiogenesis inhibitors |
| 06/24/1999 | WO1999031087A1 Cyclic imide-substituted pyridylalkane, alkene and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 06/24/1999 | WO1999031067A1 Heterocyclic cytotoxic agents |
| 06/24/1999 | WO1999031066A1 Pyridones as src family sh2 domain inhibitors |
| 06/24/1999 | WO1999031065A1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 06/24/1999 | WO1999031064A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 06/24/1999 | WO1999031063A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides |
| 06/24/1999 | WO1999031061A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031060A2 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants |
| 06/24/1999 | WO1999030741A2 Agent for gene therapy of tumor, neurodegenerative, cardiovascular and autoimmune diseases |
| 06/24/1999 | WO1999030734A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity |
| 06/24/1999 | WO1999030720A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 06/24/1999 | WO1999030713A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030710A1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 06/24/1999 | WO1999030709A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030707A1 Multicatalytic protease inhibitors for use as anti-tumor agents |
| 06/24/1999 | WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof |